|
|
Other links at Articles > Business of Medicine |
| 1. |
Bivalirudin "Nonapprovable" for ACUITY Indication
|
|
|
The US FDA has issued a "not-approvable" letter to the Medicines Company for an additional dosing regimen of the drug covering upstream treatment of ACS initiated in the emergency department, based on the ACUITY trial. Heartwire
|
| 2. |
Problems With Baxter Heparin Still Unresolved
|
|
|
Because of continuing severe adverse reactions, Baxter has stopped manufacturing multiple-dose vials of heparin. The FDA is recommending that heparin manufactured by other companies or alternative anticoagulants be used if possible. Medscape Medical News
|
| 3. |
UK GPs Urged to Accept Later Surgeries
|
|
|
Health Secretary Alan Johnson has written to every family doctor in England urging them to accept plans to make them work evenings and weekends. Reuters Health Information
|
| 5. |
Humana First-Quarter Profit Rises 13 Percent
|
|
|
Health insurer Humana Inc said on Monday that first-quarter profit rose nearly 13 percent, beating dramatically reduced expectations, helped by its commercial plans for employers and a lower-than-expected tax rate. Reuters Health Information
|
|
|
